Jon G. Mabley

8.0k total citations
85 papers, 6.7k citations indexed

About

Jon G. Mabley is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Jon G. Mabley has authored 85 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 19 papers in Cardiology and Cardiovascular Medicine and 17 papers in Molecular Biology. Recurrent topics in Jon G. Mabley's work include PARP inhibition in cancer therapy (27 papers), Pancreatic function and diabetes (13 papers) and Adenosine and Purinergic Signaling (12 papers). Jon G. Mabley is often cited by papers focused on PARP inhibition in cancer therapy (27 papers), Pancreatic function and diabetes (13 papers) and Adenosine and Purinergic Signaling (12 papers). Jon G. Mabley collaborates with scholars based in United States, United Kingdom and Hungary. Jon G. Mabley's co-authors include Csaba Szabó, Pál Pacher, Lucas Liaudet, Francisco García Soriano, György Haskó, Andrew L. Salzman, László Virág, Anita Marton, Garry J. Southan and Éva Szabó and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Medicine.

In The Last Decade

Jon G. Mabley

85 papers receiving 6.6k citations

Peers

Countries citing papers authored by Jon G. Mabley

Since Specialization

Citations

This map shows the geographic impact of Jon G. Mabley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon G. Mabley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon G. Mabley more than expected).

Fields of papers citing papers by Jon G. Mabley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon G. Mabley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon G. Mabley. The network helps show where Jon G. Mabley may publish in the future.

Co-authorship network of co-authors of Jon G. Mabley

This figure shows the co-authorship network connecting the top 25 collaborators of Jon G. Mabley. A scholar is included among the top collaborators of Jon G. Mabley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon G. Mabley. Jon G. Mabley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Divergent effects of HIV reverse transcriptase inhibitors on pancreatic beta-cell function and survival: Potential role of oxidative stress and mitochondrial dysfunction 2022 ·Life Sciences ·(unknown), (unknown), (unknown), Rían W. Manville, Jon G. Mabley	8
2	Lipotoxicity in renal proximal tubular cells: Relationship between endoplasmic reticulum stress and oxidative stress pathways 2010 ·Free Radical Biology and Medicine ·(unknown), Jon G. Mabley, Mohamed Samai, Martyn A. Sharpe, Irene C. Green, Prabal K. Chatterjee	60
3	Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy 2008 ·Journal of Cellular and Molecular Medicine ·Mohanraj Rajesh, Partha Mukhopadhyay, Sándor Bátkai, Bani Mukhopadhyay, Vivek Patel, György Haskó, Csaba Szabó, Jon G. Mabley, Lucas Liaudet, Pál Pacher	76
4	Role of Nitrosative Stress and Peroxynitrite in the Pathogenesis of Diabetic Complications. Emerging New Therapeutical Strategies 2005 ·Current Medicinal Chemistry ·Pál Pacher, Irina G. Obrosova, Jon G. Mabley, Csaba Szabó	281
5	Angiotensin II-Mediated Endothelial Dysfunction: Role of Poly(ADP-ribose) Polymerase Activation 2004 ·Molecular Medicine ·Csaba Szabó, Pál Pacher, Zsuzsanna K. Zsengellér, Anne Vaslin, Katalin Komjáti, Rita Benkő, Min Chen, Jon G. Mabley, Márk Kollai	68
6	Inhibition of Poly (ADP-ribose) Polymerase Attenuates Acute Lung Injury in an Ovine Model of Sepsis 2004 ·Shock ·Kazunori Murakami, Perenlei Enkhbaatar, Katsumi Shimoda, Robert A. Cox, Ann S. Burke, Hal K. Hawkins, Lillian D. Traber, Frank C. Schmalstieg, Andrew L. Salzman, Jon G. Mabley, Katalin Komjáti, Pál Pacher, Zsuzsanna K. Zsengellér, Csaba Szabó, Daniel L. Traber	69
7	The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Gwen S. Scott, Rhonda Kean, Tatiana Mikheeva, Marzena J. Fabis, Jon G. Mabley, Csaba Szabó, D. Craig Hooper	64
8	Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways 2004 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Jon G. Mabley, Pál Pacher, Péter Bai, Rebecca Wallace, Sunali Goonesekera, László Virág, Garry J. Southan, Csaba Szabó	23
9	Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep 2003 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Katsumi Shimoda, Kazunori Murakami, Perenlei Enkhbaatar, Lillian D. Traber, Robert A. Cox, Hal K. Hawkins, Frank C. Schmalstieg, Katalin Komjáti, Jon G. Mabley, Csaba Szabó, Andrew L. Salzman, Daniel L. Traber	80
10	Flagellin from Gram-Negative Bacteria is a Potent Mediator of Acute Pulmonary Inflammation in Sepsis 2003 ·Shock ·Lucas Liaudet, (unknown), Oleg V. Evgenov, Kanneganti Murthy, Pál Pacher, (unknown), Jon G. Mabley, Anita Marton, Francisco García Soriano, М. Yu. Кirov, Lars J. Bjertnæs, Andrew L. Salzman	88
11	Activation of Poly(ADP-Ribose) Polymerase-1 Is a Central Mechanism of Lipopolysaccharide-Induced Acute Lung Inflammation 2002 ·American Journal of Respiratory and Critical Care Medicine ·Lucas Liaudet, Pál Pacher, Jon G. Mabley, László Virág, Francisco García Soriano, György Haskó, Csaba Szabó	174
12	Inosine Exerts a Broad Range of Antiinflammatory Effects in a Murine Model of Acute Lung Injury 2002 ·Annals of Surgery ·Lucas Liaudet, Jon G. Mabley, Pál Pacher, László Virág, Francisco García Soriano, Anita Marton, György Haskó, Edwin A. Deitch, Csaba Szabó	88
13	Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents* 2002 ·Critical Care Medicine ·Prakash G. Jagtap, Francisco García Soriano, László Virág, Lucas Liaudet, Jon G. Mabley, Éva Szabó, György Haskó, Anita Marton, (unknown), Ferenc Gallyas, Balázs Sümegi, Dale G. Hoyt, Erkan Baloglu, (unknown), Andrew L. Salzman, Garry J. Southan, Csaba Szabó	158
14	Inosine Reduces Systemic Inflammation and Improves Survival in Septic Shock Induced by Cecal Ligation and Puncture 2001 ·American Journal of Respiratory and Critical Care Medicine ·Lucas Liaudet, Jon G. Mabley, Francisco García Soriano, Pál Pacher, Anita Marton, György Haskó, Csaba Szabó	90
15	Inhibition of the Na+/H+ antiporter suppresses IL-12 p40 production by mouse macrophages 2001 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Zoltán Németh, Jon G. Mabley, Edwin A. Deitch, (unknown), György Haskó	29
16	An Inhibitor of Inducible Nitric Oxide Synthase and Scavenger of Peroxynitrite Prevents Diabetes Development in NOD Mice 2001 ·Journal of Autoimmunity ·Wilma L. Suarez‐Pinzon, Jon G. Mabley, Ken Strynadka, Robert F. Power, Csaba Szabó, Alex Rabinovitch	78
17	Inosine Inhibits Inflammatory Cytokine Production by a Posttranscriptional Mechanism and Protects Against Endotoxin-Induced Shock 2000 ·The Journal of Immunology ·György Haskó, David G. Kuhel, Zoltán Németh, Jon G. Mabley, Robert F. Stachlewitz, László Virág, Zsolt Lohinai, Garry J. Southan, Andrew L. Salzman, Csaba Szabó	280
18	INTERLEUKIN 1β-MEDIATED INHIBITION OF ARGINASE IN RINm5F CELLS 1997 ·Cytokine ·James M. Cunningham, Jon G. Mabley, I C Green	12
19	The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F 1994 ·Molecular and Cellular Endocrinology ·James M. Cunningham, Jon G. Mabley, Carol A. Delaney, I.C. Green	54
20	Endogenous γ-aminobutyric acid tonically inhibits release of α-melanocyte-stimulating hormone from rat hypothalamic slices 1991 ·European Journal of Pharmacology ·Jon G. Mabley, C. Wayman, John F. Wilson	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact